Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 09:32AM EDT. Market open.
| Previous Close | 269.38 |
| Open | 265.72 |
| Bid | 267.16 x 300 |
| Ask | 269.70 x 300 |
| Day's Range | 265.72 - 268.76 |
| 52 Week Range | 211.71 - 329.72 |
| Volume | |
| Avg. Volume | 2,957,317 |
| Market Cap | 144.156B |
| Beta (5Y Monthly) | 0.60 |
| PE Ratio (TTM) | 21.50 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 9.00 (3.34%) |
| Ex-Dividend Date | May 16, 2024 |
| 1y Target Est | N/A |
- Insider Monkey
20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
- Zacks
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
© 2024 Yahoo. All rights reserved.